Cue Biopharma(CUE) - 2024 Q1 - Quarterly Results

Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights • CUE-101 abstract accepted for an oral presentation and poster presentation at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting scheduled for May 31-June 4, 2024. • Expanded pipeline to include the preclinical CUE-500 series for the treatment of autoimmune and inflammatory diseases via T cell-mediated B cell depletion. First Quarter 2024 Financial Results As of March 31, 2024, the Company ...